Table: Oncolys Biopharma -2016 parent results

Oncolys Biopharma

08/02/2017 06:00

Feb 8 (Reuters)-  
          Oncolys Biopharma Inc.  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                  Year ended      Year ended        Year to         NEXT    
               Dec 31, 2016    Dec 31, 2015     Dec 31, 2017      YEAR      
                  LATEST         YEAR-AGO         COMPANY        COMPANY    
                 RESULTS          RESULTS         FORECAST     H1 FORECAST  
  Sales          178 mln          121 mln         200 mln                   
               (+47.0 pct)     (+321.2 pct)     (+112.4 pct)                
  Operating    loss 861 mln    loss 951 mln      loss 1.40                  
  Recurring    loss 864 mln    loss 854 mln      loss 1.40                  
  Net          loss 931 mln    loss 857 mln      loss 1.40                  
  EPS        loss 101.18 yen  loss 93.35 yen  loss 152.08 yen               
  Ann Div          NIL              NIL             NIL                     
  -Q2 Div          NIL              NIL             NIL                     
  -Q4 Div          NIL              NIL             NIL                     
   
  NOTE - Oncolys Biopharma Inc..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T  
  ((Tokyo Headline News Desk +813 6441 1812))